LINS01 Compounds as Vasodilating Agents: Investigation of Potency on an Aortic Ring Ex Vivo Model

Vol. 1, 2019 - 108963
Poster and Oral (selected)
Favorite this paper
How to cite this paper?
Abstract

Cardiovascular diseases are the most relevant death cause worldwide1. Although there are several cardiovascular drugs, new potent vasodilating agents are always pursuited2. We serendipitously found that LINS01005 is a potent vasodilator in rats’ aorta, and thus novel LINS01 compounds were examined. The rings [with (E+) and without (E-) endothelium] were extracted from Wistar rats (n=6/group) and placed in an isolated organ bath equipped with a tensiometer3. The rings were pre-contracted with norepinephrine and the vasodilating potency measured as –logEC50 (concentration to reduce 50% of the tension, pEC50). LINS01005 was the most potent [pEC50 7.1(E+) and 6.8(E-)] followed by the LINS01011 [pEC50 6.8(E+) and 5.5(E-)], being comparable to several known drugs. SAR analysis suggests that substitution in the aromatic ring is detrimental to the activity, and that N-phenylpiperazine is necessary to keep the efficacy. In summary, this work added information to better designing a new set of compounds.

Track
  • 2. Medicinal Chemistry of Synthetic Compounds
Keywords
vasodilating agents
cardiovascular agents
SAR
aortic rings
vasodilating activity